The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

NCT06075147 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

2500

Enrollment

INDUSTRY

Sponsor class

Conditions

Visual Impairment
Neovascular Age-related Macular Degeneration (nAMD)
Diabetic Macula Edema (DME)

Interventions

DRUG: Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)

Sponsor

Bayer